Mark Iwicki's Colleagues at Akero Therapeutics
Reshma Shringarpure
Vice President, Clinical Research and Medical Affairs
Mark Iwicki's Contact Details
HQ
650-487-6488
650-487-6488
Location
316 Huntington Avenue,Boston,Massachusetts,02115,United States
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Company
Akero Therapeutics
Akero Therapeutics
Mark Iwicki's Company Details
Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.
Frequently Asked Questions about Mark Iwicki
Mark Iwicki currently works for Akero Therapeutics.
Mark Iwicki's role at Akero Therapeutics is Board Chair.
Mark Iwicki's email address is ***@pulmatrix.com. To view Mark Iwicki's full email address, please signup to ConnectPlex.
Mark Iwicki works in the Research industry.
Mark Iwicki's colleagues at Akero Therapeutics are John Schembri, Jimmie Zhang, Reshma Shringarpure, Yasmine Rafidi, Brittany Temple, Arian Zari, Matthew Minerva and others.
Mark Iwicki's phone number is 650-487-6488